Precipio Adds Substantial Pathology Customer to its Diagnostic Services DivisionGlobeNewsWire • 05/04/23
Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) CombinedGlobeNewsWire • 04/19/23
CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customersGlobeNewsWire • 03/07/23
Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual ConferenceGlobeNewsWire • 11/07/22
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™GlobeNewsWire • 09/15/22
Sharon Robins Joins Precipio's Products Division as Senior Director of Laboratory & Hospital SalesGlobeNewsWire • 08/24/22
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/16/22
Toni-Ann Mills Joins Precipio's Products Division to Lead Channel Partner Training, Learning & DevelopmentGlobeNewsWire • 08/10/22